GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast A/S (MEX:0QBO) » Definitions » Cyclically Adjusted PS Ratio

Coloplast A/S (MEX:0QBO) Cyclically Adjusted PS Ratio : 9.74 (As of Jun. 21, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Coloplast A/S Cyclically Adjusted PS Ratio?

As of today (2024-06-21), Coloplast A/S's current share price is MXN2082.59. Coloplast A/S's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was MXN213.91. Coloplast A/S's Cyclically Adjusted PS Ratio for today is 9.74.

The historical rank and industry rank for Coloplast A/S's Cyclically Adjusted PS Ratio or its related term are showing as below:

MEX:0QBO' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 7.55   Med: 10.93   Max: 16.78
Current: 8.89

During the past years, Coloplast A/S's highest Cyclically Adjusted PS Ratio was 16.78. The lowest was 7.55. And the median was 10.93.

MEX:0QBO's Cyclically Adjusted PS Ratio is ranked worse than
84.76% of 479 companies
in the Medical Devices & Instruments industry
Industry Median: 2.12 vs MEX:0QBO: 8.89

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Coloplast A/S's adjusted revenue per share data for the three months ended in Mar. 2024 was MXN70.912. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is MXN213.91 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Coloplast A/S Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Coloplast A/S's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast A/S Cyclically Adjusted PS Ratio Chart

Coloplast A/S Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.75 14.58 13.55 8.96 8.09

Coloplast A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.03 9.43 8.09 8.28 9.74

Competitive Comparison of Coloplast A/S's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Coloplast A/S's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast A/S's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast A/S's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Coloplast A/S's Cyclically Adjusted PS Ratio falls into.



Coloplast A/S Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Coloplast A/S's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=2082.59/213.91
=9.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coloplast A/S's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Coloplast A/S's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=70.912/118.4000*118.4000
=70.912

Current CPI (Mar. 2024) = 118.4000.

Coloplast A/S Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 34.694 99.700 41.201
201409 35.394 99.700 42.033
201412 37.859 99.400 45.096
201503 35.720 100.200 42.208
201506 39.135 100.300 46.197
201509 43.515 100.200 51.419
201512 43.031 99.800 51.051
201603 43.529 100.200 51.435
201606 48.425 100.600 56.993
201609 51.429 100.200 60.770
201612 51.754 100.300 61.093
201703 49.429 101.200 57.830
201706 50.312 101.200 58.863
201709 54.241 101.800 63.086
201712 58.080 101.300 67.884
201803 57.192 101.700 66.583
201806 61.365 102.300 71.023
201809 58.329 102.400 67.443
201812 60.836 102.100 70.548
201903 60.502 102.900 69.616
201906 62.798 102.900 72.257
201909 63.027 102.900 72.521
201912 61.978 102.900 71.314
202003 78.635 103.300 90.130
202006 72.154 103.200 82.781
202009 75.371 103.500 86.222
202012 72.457 103.400 82.968
202103 72.930 104.300 82.789
202106 73.113 105.000 82.444
202109 77.824 105.800 87.092
202112 75.557 106.600 83.921
202203 76.152 109.900 82.042
202206 78.574 113.600 81.894
202209 76.396 116.400 77.709
202212 79.792 115.900 81.513
202303 73.985 117.300 74.679
202306 71.638 116.400 72.869
202309 69.070 117.400 69.658
202312 75.085 116.700 76.179
202403 70.912 118.400 70.912

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Coloplast A/S  (MEX:0QBO) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Coloplast A/S Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Coloplast A/S's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast A/S (MEX:0QBO) Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast A/S (MEX:0QBO) Headlines

No Headlines